Rare diseases
Investigational molecules
Locations
Back to France3 332 clinical trials in Corbeil Essonnes, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
FranceStudy on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
FranceStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
FranceStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
FranceStudy of benralizumab compared to placebo for treatment of patients with Hypereosinophilic Syndrome (HES)
FranceStudy on the Safety and Effectiveness of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) for Adults with Amyotrophic Lateral Sclerosis (ALS)
FranceStudy on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis
FranceStudy on Long-Term Safety of GSK1070806 for Patients with Moderate to Severe Atopic Dermatitis
FranceStudy Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine
FranceStudy of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
FranceStudy of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis
FranceStudy of Lorigerlimab and Docetaxel for Patients with Metastatic Castration-Resistant Prostate Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on novel treatments for Type 1 and Type 2 Diabetes, particularly investigating therapies like tirzepatide for glycemic control and cardiovascular outcomes in patients with obesity and diabetes.
Groundbreaking trials in Multiple Myeloma treatment, evaluating combinations of targeted therapies including elranatamab, lenalidomide, and daratumumab for newly diagnosed and relapsed cases.
Research examining innovative treatments for Immune Thrombocytopenia, Polymyalgia Rheumatica, and Lupus Nephritis, focusing on targeted therapies and steroid-sparing approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
